Skip to Content
Download as PDF

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

First Session, Forty-first Parliament, 2011-12-13

Chair: The Honourable KELVIN KENNETH OGILVIE


Wednesday, March 20, 2013
Thursday, March 21, 2013

Issue No. 34

Twenty-ninth and thirtieth meetings on:

Study on prescription pharmaceuticals in Canada


WITNESSES

Wednesday, March 20, 2013

Rx&D:

Walter Robinson, Vice President, Government Relations;

Jared Rhines, Scientific and Regulatory Affairs.

BIOTECanada:

Andrew Casey, President and Chief Executive Officer.

Canadian Generic Pharmaceutical Association:

David Windross, Vice-President of External Relations, Teva Canada.

Thursday, March 21, 2013

Psychiatric Medication Awareness Group:

Janet Currie, Representative.

Canadian Organization for Rare Disorders:

Maureen Smith, Secretary.


MEMBERS OF THE COMMITTEE

The Honourable Kelvin Kenneth Ogilvie, Chair

The Honourable Art Eggleton, P.C., Deputy Chair

and

The Honourable Senators:

Cordy, *Cowan (or Tardif), Dyck, Eaton, Enverga, *LeBreton, P.C. (or Carignan), Martin, Mercer, Munson, Seidman, Seth, Verner, P.C.

* Ex officio members

(Quorum 4)

Changes in membership of the committee:

Pursuant to rule 12-5, membership of the committee was amended as follows:

The Honourable Senator Mercer replaced the Honourable Senator Merchant (March 20, 2013).

The Honourable Senator Dyck replaced the Honourable Senator Campbell (March 18, 2013).

The Honourable Senator Eaton replaced the Honourable Senator Raine (March 14, 2013).